Showing results (21-30 of 470) with videos related to
Sort By:
Pageof 47
Current Opinion in Oncology|July 17, 2009
The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphomaLauren S Maeda, Ranjana H AdvaniCase Reports in Oncology|October 27, 2017
Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88L265P MutationRyan C Lynch, Ranjana H AdvaniExpert Opinion on Emerging Drugs|April 27, 2024
Emerging immunotherapies in the Hodgkin lymphoma armamentariumMichael A Spinner, Ranjana H AdvaniMedical Hypotheses|February 1, 1991
A hypothetical model to explain the 'termination' of chronic myeloid leukemia into blastic crisisS D Banavali, S H AdvaniReviews of Infectious Diseases|November 1, 1989
Pattern of infection in hematologic malignancies: an Indian experienceS H Advani, S D BanavaliIndian Journal of Cancer|December 1, 1993
Maxillary extragonadal germ cell tumor: a case reportR Nair, S Krishnamurthy, S H AdvaniIndian Journal of Pediatrics|August 19, 2003
Benign multilocular cystic nephromaSaika Somjee, Rajesh Jindel, S H AdvaniHematological Oncology|June 9, 2023
Novel agents in relapsed/refractory diffuse large B-cell lymphomaGaurav Varma, Jordan Goldstein, Ranjana H AdvaniThe Journal of the Association of Physicians of India|January 11, 2007
Myelomatous pleural effusionSharmila Ghosh, R Gopal, S H AdvaniSeminars in Hematology|July 14, 2024
The role of response adapted therapy in the era of novel agentsJoseph G Schroers-Martin, Ranjana H AdvaniPageof 47